GlaxoSmithKline Plc’s diabetes pill Avandia should stay on the market even though data suggest it may raise the risk of a heart attack for some patients, U.S. advisers said on Monday.
Read full story
A federal drug advisory committee voted to recommend that the diabetes drug Avandia remain on the market, despite finding that it raised the risks of heart attacks.
Read full story
July 29, 2007
Diabetes Epidemic Having Devastating Effects In New York City, New Report Shows (Medical News Today)
The diabetes epidemic is taking a large and growing toll on New York City, a new Health Department report shows, as death rates, debilitating complications, and hospitalization costs soar. Some 500,000 New Yorkers — one out of eight adults — have been diagnosed with diabetes. Another 200,000 have diabetes but don’t yet know it. The death rate from diabetes rose by 75% between 1990 and 2003. …
Read full story
Two popular drugs used to treat late-onset diabetes may double the risk of heart failure, according to a new study.
Read full story
